Send us message to learn more about InnoHK
CONTACT US
Biomedical
Advanced Biomedical Instrumentation Centre
Driving Closer Collaboration in Biomedical Instrumentation for Greater Impact on Health
The collaboration between HKU’s Faculty of Engineering and Harvard’s SEAS will facilitate design of devices and treatments that will impact healthcare in Asia and worldwide, as well as leverage Hong Kong’s strategic location in the Greater Bay Area with its unique industrial scene and opportunities to develop and commercialise our R&D efforts.
Professor Anderson Shum Ho Cheung
Professor and Associate Head in the Department of Mechanical Engineering at the Faculty of Engineering at the University of Hong Kong
Hong Kong
Driving Closer Collaboration in Biomedical Instrumentation for Greater Impact on Health
Behind-the-scenes, and not known to many, biomedical instrumentation plays an ever-increasing critical role in the healthcare industry by enabling more accurate diagnoses, effective treatments, and earlier intervention and prevention capabilities. The work involves development of cutting-edge medical devices, mechanics and sensors, and calls for increased collaboration among some of the world’s most talented scientists, engineers and clinicians. It will also require building an environment well suited to facilitate commercialisation of research results into real-world applications that are accessible to a wider population.
The programme team leaders discuss during the planning of the Advanced Biomedical Instrumentation Centre.
![[Left to Right] Professor Anderson Shum, Professor David Weitz, Dr. Paddy Chan, Professor Barbara Chan and Professor Kenneth Wong are key leaders of the research programmes in the Centre.](/media/q0gjwnfm/photo-2.jpg)
[Left to Right] Professor Anderson Shum, Professor David Weitz, Dr. Paddy Chan, Professor Barbara Chan and Professor Kenneth Wong are key leaders of the research programmes in the Centre.
Professor Anderson Shum (Right) from HKU Engineering, the parent institution, and Professor David Weitz (Left) from Harvard School of Engineering and Applied Sciences, the participating institution, direct the scientific endeavors in the Centre.
The Centre will be headquartered in Hong Kong Science Park.
The Centre will be headquartered in Hong Kong Science Park.
The Centre aims to combine the expertise in fluidics, optics, materials, sensors and others from HKU Engineering and Harvard SEAS to develop biomedical instrumentations that enhance screening, detecting, treating and monitoring diseases. [Left to Right] Professor Barbara Chan, Dr. Paddy Chan, Professor Kenneth Wong, Professor Anderson Shum and Professor David Weitz
![Interactions of the international and multidisciplinary teams will drive closer collaboration in biomedical instrumentation for greater impact on health. [Left to Right] Professor Kenneth Wong, Professor David Weitz and Dr. Paddy Chan](/media/4qrkqx10/photo-6.jpg)
Interactions of the international and multidisciplinary teams will drive closer collaboration in biomedical instrumentation for greater impact on health. [Left to Right] Professor Kenneth Wong, Professor David Weitz and Dr. Paddy Chan
Advanced Biomedical Instrumentation Centre has been established with a mission to accelerate progress in translating advanced biomedical instrumentation from research and development (R&D) into real-world healthcare solutions that benefit people in Hong Kong and around the world. The research lab aims to foster collaboration among top-notch engineers, scientists and clinicians in the US and Hong Kong to develop next-generation microfluidics and low-cost instrumentation technologies. It also takes advantage of Hong Kong’s vibrant start-up community to commercialise research work tailored for Asian patients.
Chosen for their potential translation and ability to make an impact in biomedical instrumentation that will have a huge potential to help a broader spectrum of patients, the Centre’s R&D activities will focus on four research programmes:
- Affordable Screening Tests: promote widespread screening for early disease detection
- Personalised Companion Diagnostics: Develop new insights into disease causation to enable personalised treatments
- Strategic Therapeutic Approaches: enable new treatments that require new delivery strategies
- Advanced Medical Device Components: enhance automated and personalised medical devices for disease management that requires advanced components.
The Centre will also serve as fertile ground to nurture Hong Kong’s young “rising stars” and groom the next generation of researchers, who will ultimately lead research programmes sustainably into the future. The instrumentation developed by the Centre will also create very rapid, highly sensitive and easily scalable testing kits for COVID-19 and other emerging pandemic viruses, serving one of the greatest current needs worldwide.
Project team members
-
Henry ChowProfessor of The Hong Kong Polytechnic University
Hong kong -
Henry Chow
Professor of The Hong Kong Polytechnic University
Hong Kong -
Henry Chow
Professor of The Hong Kong Polytechnic University
Hong Kong
In this project
You may also like
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
